Kalvista Pharmaceuticals (KALV) Q3 2025 Earnings

Sep 11Confirmed
Q4 2024
Q1 2025
Q3 2025
Q3 2025
-1.12
-1.01
-0.91
-0.8

Details

Expected EPS
-0.953333
Actual EPS
-1.12
Surprise EPS
-0.17
Surprise Percent
-17.48%

Description

⁨Kalvista Pharmaceuticals⁩ (⁦KALV⁩) has reported earnings of ⁦-1.12⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts